How do you meet data management and biostatistical expertise needs for a hospital?
Providing expertise to researchers at Children’s Hospital of Philadelphia
Challenge
When the Children’s Hospital of Philadelphia (CHOP) needed experts in data management and biostatistics support for its many research studies, it turned to Westat.
Solution
Westat expanded and operated the hospital’s Biostatistics and Data Management Core (BDMC), which works on a wide variety of studies in virtually all the subspecialties of pediatric medicine.
We have provided expertise in a number of ways:
- Evaluating the needs of ongoing and proposed studies
- Meeting with researchers to discuss their data management and biostatistical needs
- Helping researchers with study design, data management, and statistical analyses
- Helping researchers write grant applications to get funding for studies
Results
We have supported more than 100 studies in cardiology, neurology, oncology, nephrology, infectious diseases, and injury prevention. The studies have varied from gene therapy clinical trials to observational and epidemiologic investigations.
The researchers we work with have presented their studies at scientific meetings and published them in peer-reviewed journals.
Their research is supporting evidence-based decisionmaking on a variety of important health issues.
Focus Areas
Clinical Infrastructure and Support Clinical Research Clinical Trials Disease Epidemiology Public HealthCapabilities
Biostatistics and Epidemiology Technical AssistanceSenior Expert Contact
Julie DiStefano-Pappas
Principal Research Associate
-
Expert Interview
Safeguarding Data Privacy: Innovations at WestatOctober 2025
Protecting the privacy of people who respond to surveys and censuses is a critical responsibility in federal data collection. During the 2010 Decennial Census, the…
-
Expert Interview
Novel Strategies Transform Clinical Trials Into Future OpportunitiesOctober 2025
For the rigorous evaluation of novel medicines, clinical trials are essential to ensure safety and efficacy. However, clinical trials are experiencing turbulent times due to…
-
Expert Interview
Real-World Insights: Nirsevimab’s Protection Against RSV in InfantsSeptember 2025
Each year in the U.S., respiratory syncytial virus, commonly known as RSV, leads to approximately 58,000 to 80,000 hospitalizations among children under age 5. The…